Sonia M. Poli, PhD

Sonia M. Poli, PhD, is a senior pharmaceutical executive and board director with 25+ years of global experience in R&D and is currently the Head of Translational Sciences at Booster Therapeutics. With a PhD in Industrial Chemistry from the University of Milan and post-doctoral training at CNRS Paris, Dr. Poli has participated in both discovery and late-stage drug development programs across a wide range of therapeutic areas (neurodegeneration, psychiatry, rare diseases, and oncology). 

Previously, she served as Chief Scientific Officer and Vice President in multiple biotech companies, including Addex Therapeutics, AC Immune, Minoryx, and Sibylla Biotech, where she established and led cross-functional teams covering non-clinical development, CMC, regulatory, and early clinical development. Through her consulting firm, she has advised 10+ biotechnology companies, contributing to the definition of preclinical strategy, FiH study execution, and regulatory engagement (FDA, EMA, PMDA) from IND through market authorization. Dr. Poli has authored 50+ scientific publications.